Ticker Symbol: SBIZF

SymBio Pharmaceuticals Limited

Exchange: US OTC Country: JP Currency: USD Asset Type: Common Stock CIK:0001625751

Company Profile

SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded by Fuminori Yoshida on March 25, 2005 and is headquartered in Tokyo, Japan.

Sector: Health Technology

Industry: Pharmaceuticals: Other

Standard Industrial Classification Code (SIC code): 2834

Address: Toranomon 30 Mori Building

Website: http://www.symbiopharma.com

CEO: Fuminori Yoshida

Tags:

Health Technology
Pharmaceuticals: Other

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: $2.90 - -

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change 0.00%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 38474506

Valuation

Market Cap: 11.2B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: December 29, 2021